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Abstract 
Purpose: The purpose of this study was to explore factors influencing decision-making about 
disclosure of Assisted Reproductive Technology (ART) use in the workplace.  
Design: A qualitative study design was used. Thirty-one women and six men who were using 
or had recently used ART were recruited from British fertility networks and interviewed. 
Data were transcribed verbatim and thematically analysed.  
Findings: Two main strands were identified each encompassing two themes: i) ‘Concerns 
about disclosure’ covered the very personal nature of disclosing ART treatment and also 
career concerns and ii) ‘Motives for disclosure’ covered feeling it was necessary to disclose 
and also the influence of workplace relationships. 
Research limitations: The relatively small, self-selected sample of participants was recruited 
from fertility support networks, and lacked some diversity. 
Practical implications: Clarity about entitlements to workplace support and formal protection 
against discrimination, along with management training and awareness raising about ART 
treatment is needed to help normalise requests for support and to make decisions about 
disclosure within the workplace easier.  
Originality/ value: The study has highlighted an understudied area of research in ART 
populations. The data provide insight into the challenging experiences of individuals 
combining ART with employment and, in particular, the complexity of decisions about 
whether or not to disclose. 
 
Keywords: Fertility, involuntary childlessness, assisted conception, disclosure, stigma, 
employment, communication  
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Introduction 
Recent data from the HFEA (2015) shows numbers of ART treatments in the United 
Kingdom (UK) have more than doubled between 1992 and 2007, and is continuing to 
increase. Treatment is sought by those who experience infertility or subfertility for medical 
reasons (NHS, 2017), including following the treatment of cancers (Vitale et al, 2017). Vitale 
et al (2017) reported that the experience of infertility due to cancer in women can be more 
devastating than the cancer itself and the possibility of having a child after cancer can have 
beneficial effects on the therapeutic process. However, both the treatment of disease and 
subsequent different types of ART’s are known to have an effect on the emotional state of 
women and the failure of treatment may influence the quality of life of the woman and the 
relationship within the couple (Vitale et al, 2016). Treatment for infertility is also sought by 
those involuntarily sub fertile through lifestyle factors, such as delayed childbearing 
associated with a lack of partner (Salomon et al., 2015), health concerns (Holton et al., 2011), 
or educational and employment reasons (Birch Peterson et al., 2015). These delays have 
important consequences for fertility prospects, which are diminished and may require 
treatment. Single men and women, and same sex couples are also increasingly seeking 
treatment in the UK to overcome involuntary childlessness and build a family (van den Akker, 
2017). Many involuntary childless people never seek treatment (Greil and Mcquillan, 2004) 
and some of these are too depressed to seek help (Crawford et al., 2017). However, especially 
for women who do seek treatment, assisted conception is time consuming, costly, physically 
uncomfortable, unpredictable and can lead to effects on mood and performance in work and 
non-work domains (van den Akker, 2012). The experience of infertility or involuntary 
childlessness (the preferred term used in this paper) is also influenced by the social context in 
which it takes place, including socioeconomic status, religion, culture, gender, gendered 
practices and direct and indirect messages women and men receive (Bell, 2016). While 
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women using assisted conception experience greater levels of distress than men (Greil, 
Slauson-Blevis, & McQullian, 2010), men too may need to cope with anxiety or depression 
(Fisher and Hammarberg, 2012). They may invest time and emotional efforts into diagnostic 
investigations and providing sperm samples, as well as supporting their partner through the 
numerous tests and invasive treatment processes. Therefore, men and women who are 
involuntarily childless for various reasons face devoting substantial amounts of time - 
including time from work - and emotional energy to a family building process which has an 
uncertain outcome.  
 
Research to date has neglected the experiences of combining ART treatment with 
employment. This is an important gap in the research as ART users need to disclose this 
treatment process to supervisors and colleagues to obtain workplace support. However, 
disclosure of personal aspects of life at work, where most people spend much of their time, 
can be fraught with difficulties. Communication Privacy Management (CPM) theory 
(Petronio, 2002) suggests that individuals maintain and coordinate privacy boundaries with 
potential communication partners. These privacy boundaries draw divisions between private 
and public information. The boundaries may be permeable or rigid depending on the 
perceived benefits and costs of disclosure.  
 
Thus despite the need to disclose to obtain workplace support, there are a number of potential 
costs or reasons why workers may feel ambivalent or fearful about disclosing ART use. 
Firstly, not everyone feels comfortable with disclosures that blur private and professional 
boundaries. For example, there may be concerns about stigma (Whiteford and Gonzalez, 
1995). In particular, reasons why men do not disclose using ART to those outside of their 
immediate personal relationships tend to centre on shame (Lee and Chu, 2001) and fear of 
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thoughtless comments (Throsby and Gill, 2004). This is problematic because research has 
shown that social support is associated with less stress (Martins et al., 2013) and less 
depression, and anxiety and greater positive adjustment to involuntary childlessness (Bute, 
2013; Mahajan et al., 2009). 
 
Secondly, gendered assumptions about ideal workers, who do not allow personal life (Holt 
and Lewis, 2011) or problematic and unpredictable (female) bodies to interfere with work 
(Swan, 2005), may inhibit some women using ART from disclosing. Due to the paucity of 
research on disclosure of ART treatment in the workplace, work on pregnancy in the 
workplace may serve as an example. Pregnant women applying for jobs have been treated 
with hostility (Hebl et al., 2007) and research on bodily issues at work (e.g. Gatrell, 2011) 
shows that pregnant employees (at least among professional and managerial women) report 
feeling side-lined or discriminated against due to assumptions that they are no longer 
committed to their work (King and Botsford, 2009). Pregnant women respond by “supra-
performing” (Gatrell, 2011) to minimize the impact of pregnancy at work (Costello, 2009) 
and show that they can conform to the male ideal worker. Disclosure is left to later in the 
pregnancy when the signs are obvious and the risks of miscarriage reduced. Women who are 
pregnant via non-normative routes, such as single or older women or those who used ART 
may be doubly reluctant to disclose (King and Botsford, 2009), as they will be revealing 
more than just the pregnancy. Thus disclosure of ART treatment is likely to be especially 
difficult in the workplace.  
 
Thirdly, there is evidence from other health related fields that disclosure of personal 
information at work can be perceived as risky. For example, in a study of workplace 
disclosure in breast cancer survivors, Robinson et al. (2015) found that women felt they had 
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to disclose that they had breast cancer because they feared colleagues might guess they had a 
major health problem. They also disclosed in the workplace because they wanted to be open, 
although they had concerns about confidentiality and the distress of telling people. Reasons 
for not disclosing chronic illnesses (Munir et al., 2005) and mental health issues (Brohan et 
al., 2012) in the workplace include privacy; fear of gossip, discrimination, and rejection; and 
fear of loss of social support and loss of employment.  
 
Fourthly, this previous research on disclosure of pregnancy and of chronic and mental illness 
raises questions about how comfortable ART users feel about requesting time off work. In the 
UK there are no statutory rights to conception care, such as absence from work for 
assessments of fertility status and for ART appointments and procedures. Workplace policies 
to support workers using ART are also not commonplace. This is despite evidence verifying a 
need for such support in other countries (e.g. the U.S. Family Building Act of 2001). The lack 
of policy for conception care may result in ART users feeling anxious about whether 
disclosure in the workplace will result in the provision of support, such as enabling time off 
work. For example, parents with childcare demands are often reluctant to request flexible 
working arrangements because of non-supportive workplace cultures (Friedman, 2001). 
These concerns have not been examined in ART users.  
 
Non-disclosure of stigmatized conditions can lead to living with different identities which are 
presented and maintained in different social situations. Ragins (2008) refers to ‘disclosure 
disconnects’ whereby varying degrees of disclosure in different settings result in individuals 
attempting to manage an identity that is concealed in certain settings. For example, a person 
has the dilemma to, on the one hand, show authenticity as an employee and colleague in order 
to maintain the identity of an honest person and verify the sense of self as one who has 
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meaningful (workplace) relationships (Creed and Scully, 2000), and on the other hand to 
keep private matters away from the workplace and protect themselves from experiencing 
discriminations or stigma (King and Botsford, 2009). Martins et al. (2013) suggest that if 
disclosure is perceived to be safe, and potentially leads to social support, it may be beneficial 
to disclose. Non-disclosure may be a safer strategy where confiding personal information 
may not lead to support.  
 
Issues relating to the disclosure of ART treatment in the workplace have been neglected in 
research. One exception is a study by Finamore et al. (2007). They failed to find an 
association between women’s disclosure of ART in the workplace and reduced stress but 
found that women disclosed to explain frequent absences for medical appointments. Reasons 
for non-disclosure focused on privacy. However, this study was based on questionnaires 
which precluded in depth exploration of experiences and decision-making about disclosure.  
 
The present paper is part of a larger study of work and involuntary childlessness. It explores 
ART users’ accounts of decision-making about whether to disclose to supervisors and 
colleagues in the workplace and factors influencing their decisions.  
 
Method 
Materials 
A semi-structured interview schedule was developed based on previous research and input 
from the organizations Fertility Network UK (FNUK; a UK charity supporting people who 
have ever experienced fertility problems) and Working Families (a UK charity supporting 
working parents and carers and their employers find a better balance between responsibilities 
at home and work). The interview schedule, which was part of a larger study, comprised open 
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ended questions and prompts to explore participants’ job role, aspects of their career and 
family, combining work and treatment, how they managed taking time off work, and 
decisions about and experiences of disclosure in the workplace.     
 
Participants 
A convenience sample of 37 participants was recruited. Most were members of FNUK or 
Fertility Friends (both leading online infertility and fertility support communities in the UK), 
and some were recruited through snowballing techniques. Half were in treatment and half 
were previous ART users. Twenty-six were married or co-habiting (partnered), 5 were single 
women, and 6 were married or co-habiting men. The mean age of participants was 36 (SD = 
5.58). All were white and heterosexual and were in professional or white collar jobs.  
 
Procedure 
Ethical approval was obtained for the study from the University Ethics committee. 
Participants were recruited through messages on the websites of six fertility support networks 
or organisations. Potential participants contacted the research team by email and were then 
sent an information sheet and consent form and were asked to arrange a time for the interview. 
Due to issues relating to time and location, thirty-three participants preferred to be 
interviewed by telephone while four agreed to be interviewed in their home. Interviews were 
conducted by a Research Assistant except for four early interviews which were conducted by 
two of the authors. Interviews lasted between 45 and 120 minutes, were digitally recorded 
and transcribed verbatim.  
 
Data analysis 
Transcripts from the interviews were analysed using thematic analysis (TA) with the 
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assistance of NVivo 10 software to help organise themes and subthemes and associated 
quotes. Braun and Clarke (2006) argue that as TA is not theoretically bounded, it is a flexible 
technique for identifying, analysing and reporting patterns (themes) in the data. TA was 
conducted within a realist/essentialist paradigm, such that experience and meaning were 
theorised in a relatively straight-forward way because they were considered to be reflected 
via language (Braun & Clarke, 2006). Data analysis began while data were still being 
collected and Braun and Clarke’s six-phase process was broadly used. Initially one of the 
authors and a research assistant read and re-read 25 of the transcripts in detail (step 1: 
familiarising yourself with the data). Participants’ responses were coded into groups of codes 
that summarised the content of the data, guided by the aims of the study (step 2: generating 
initial codes). These were collated into initial themes and subthemes (step 3: searching for 
themes), which were checked against the same 25 interviews (to ensure that they were all 
represented). These themes were discussed among all authors to further ensure reliability 
(step 4: reviewing themes). A further 12 transcripts were coded by the remaining two authors 
and again the themes were discussed among all authors. At this point it was decided that data 
saturation had been reached and so no further interviews took place. Themes and subthemes 
were reviewed through an iterative process throughout and were finally refined and grouped 
under four major named themes (step 5: defining and naming themes). Themes were then 
linked, enabling theorising about the disclosure process, including barriers to and facilitators 
of disclosure of ART use in the workplace. Finally quotes from participants, who were given 
pseudonyms, were selected to illustrate each theme and the findings were drafted (step 6: 
producing the report). 
 
Findings 
Thirty participants (81%) eventually disclosed their use of assisted conception to their line 
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manager because they wished to or felt it was necessary. However, all participants expressed 
concerns about disclosure and for seven (19%), these concerns deterred them from disclosing 
to their line manager. Thirty-one participants (78%) disclosed to colleagues. However, all 
participants were concerned to limit the number of colleagues who were aware they were 
having treatment.   
 
Four main themes emerged from the data and these are grouped under two key strands: 1) 
concerns about disclosure (“it’s very personal” and career concerns) and 2) motives for 
disclosure (“I felt I had to” and workplace relationships). Career concerns applied only to 
decisions about disclosing to line managers in the workplace. The other themes applied 
equally whether in relation to disclosure to line managers or colleagues. These themes and 
illustrative interview data are set out in the following sections. 
 
Strand 1: Concerns about disclosure 
The main concerns that made it difficult to disclose ART treatment in the workplace are 
related to i) the very personal nature of such disclosures and ii) career concerns.  
 
”It’s very personal” 
A major theme permeating all the accounts was concern about disclosing something that was 
considered intensely personal and private in the workplace context. As highlighted by Grace 
(partnered), participants felt “awkward and embarrassed about confiding in somebody at 
work that very personal stuff”. There was some variation in the extent to which participants 
felt uncomfortable in blurring the boundaries between work and personal life in this way.  
The men in particular and also men and women in more senior roles were most concerned to 
keep work and their personal life separate in order to remain “professional”. For those like 
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Jenny, who were reluctant to disclose treatment even outside of work, the decision making 
about disclosure at work was very difficult. 
I was so private and I wasn’t even telling my friends, I definitely didn’t want to tell 
anyone at work at all, and I really agonised over that. I wanted to keep it to myself, I 
didn’t want people to know… it helps me keep it away from work (Jenny, partnered)   
 
Reluctance to disclose this very personal information was also attributed to fear of being 
judged and included explicit references to stigma related to having treatment, especially 
among men such as Matthew and single women such as Harriet. There were also concerns 
about gossip and that people would fail to maintain confidentiality.   
...ultimately for fear of judgement. I was in a big school and I was unmarried, an 
unmarried mother seeking IVF treatment … so I kept my privacy. (Harriet, single) 
 
I think there is an element of slight anxiety I suppose in how-, what people are going 
to-, in their views of IVF and that sort of thing (Matthew, partnered) 
 
Fears about continued intrusion into this very personal issue by well-meaning colleagues who 
might enquire about treatment progress also made decisions to disclose difficult. In particular, 
there were concerns about having to disclose whether treatment had been successful 
immediately after embryo transfer, which, if not successful, would also be highly distressing. 
However, experiences of those who had disclosed varied; some found questions about 
treatment progress from colleagues with whom they had a good relationship quite supportive, 
while others felt that their anxieties about intrusion were justified. 
They were all asking at each stage, “How is it going? What stage are you at now?” 
When you are going through something like this it almost gives people permission to 
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ask questions … just very personal questions … you wouldn’t ever ask a normal 
couple who are trying to conceive, those questions. That was difficult. (Nikki, 
partnered) 
 
Nikki’s comments above illustrate an underlying frustration that people using assisted 
conception are treated differently to those trying to conceive naturally, who would not have 
to disclose so early nor be asked personal questions about their attempts to conceive. 
 I certainly can’t imagine telling a colleague that you’re trying to have a baby [if you 
are not having ART treatment]. It’s too kind of – I don’t know. You don’t tell people 
you’re having sex, do you? (Verity, partnered) 
 
This frustration about differential treatment also emerged in relation to the second theme 
relating to career concerns.  
 
Career concerns 
Concerns about the possible negative career consequences of disclosing ART treatment to 
line managers emerged as a theme, especially among the women in this sample of 
professional and white collar workers. These concerns influenced their thinking about 
whether and when to disclose and ask for support from line managers. This was a particular 
concern for single women who relied on employment and a single salary to support treatment 
and any future child if treatment was successful. The women were also concerned about 
requesting support for time off or flexibility to manage treatment and then ultimately having 
to ask for support again for maternity leave. While maternity leave is a statutory right, they 
still felt uncomfortable about what they perceived as implying “I need some time off in order 
that hopefully I can have a whole load more time off” (Sarah, partnered). They feared 
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possible career implications, including loss of career opportunities and questioning of their 
career commitment.  
 
Participants once again drew contrasts with people trying to conceive naturally. The 
perception among those who discussed possible career disadvantages was that disclosure 
would be providing advance notification, which, it was suggested, might impact on 
opportunities for promotion. For example, Nikki expanded on her earlier comments: 
I didn’t want to make it so public that it would jeopardise my roles within the team. At 
the time we were going through IVF there were quite a lot of role changes so I was 
competing for different roles within my team and therefore didn’t want to be seen as, 
okay, she’s going to have a baby so there’s no point in giving her a more senior role. 
I think that was what was most difficult because a lot of people who were trying 
naturally, they wouldn’t have to disclose any of that (Nikki, partnered) 
 
Relatedly, the decision about whether to disclose was also influenced by perceptions that line 
managers or colleagues may question their focus on and commitment to work. This 
perception that their priorities lie elsewhere could again have negative career consequences. 
Most of the men were less concerned about this. For example, Oliver (partnered) remarked 
“In terms of like if my wife does get pregnant, it will be her that’s having the time off, and so 
it doesn’t really affect me as much”. However, like most women participants, Ian, who 
worked in a job with high ideal worker expectations also feared that to disclose to his 
manager would result in his commitment to his job being questioned.  
Having worked with my boss’ boss for about six years now, his opinion would have 
been, well Ian’s doing this, he’s not interested in his career, who’s next. I absolutely 
know that they weren’t interested in promoting or pushing anyone who wasn’t giving 
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the cause 200% really. To have something massive like this revealed is a bit like 
shooting yourself in the foot really. (Ian, partnered) 
 
Participants also felt that unexplained absences due to ART treatment if they did not disclose 
could equally be interpreted in terms of lack of commitment. This was highlighted by Kerry 
(partnered) who said “I got the sense that people thought I was ducking and diving out of 
work and being unreliable”. Thus women may end up in a catch 22 situation whereby 
whether or not they disclose and whether or not treatment is successful they could be seen as 
less committed.  
 
Nevertheless, not all the women participants talked about career concerns. A counter view 
expressed by a minority of women from the outset was that having a child was so much more 
important than their job or career. 
To be quite honest, I didn’t care. If they’d turned round and said, ‘Well, asking for 
this means that you’ll never be promoted,” I would have said, “Right, I don’t give a 
stuff” quite frankly. (Angela, partnered) 
 
In summary, all participants expressed some degree of concern about disclosing what was 
considered to be the intensely personal and private experience of ART treatment in the public 
sphere of the workplace. This was compounded by fears of judgemental or stigmatising 
responses from others, as well as anxiety about further intrusive personal question about 
treatment progress. The women in particular also talked about the potential impact of 
disclosure on their careers. It was feared that having to reveal in advance that they may have 
a baby would prolong any potential negative perceptions of mothers at work by reducing 
promotional opportunities or calling into question their career commitment. The nature and 
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extent of these concerns varied according to gender, whether participants were partnered or 
single and expectations relating to their job role. However, cutting across both personal and 
career concerns about disclosure, the point was repeatedly made that people using assisted 
conception are treated differently from those trying to conceive naturally, which was 
regarded as frustrating and unfair. 
 
Strand 2: Motives for disclosure 
The main motives for disclosing ART treatment in the workplace are related to i) feeling it 
was necessary to disclose and ii) the influence of workplace relationships. 
 
“I felt I had to”  
Despite concerns about disclosure, a key motive for disclosing in the workplace was feeling 
there was little choice and it was necessary. Where participants made an early decision to 
disclose it was because they needed to request support for time off work to attend 
appointments. This was especially the case among participants who lacked any intrinsic 
flexibility in their working hours and locations. However, there were also concerns, even 
among those with more autonomy at work, that their line manager or colleagues would notice 
that they were taking time off, that their productivity had reduced or that they were being 
more emotional at work.  
I didn’t want people to think I’d just lost the plot for no reason; and I wanted people 
at work to understand why my work ethic had changed, and why I needed time off 
without trying to think up reasons. (Brenda, partnered)  
 
The need to disclose was also discussed in terms of wanting to be honest and transparent, so 
they felt they had a “responsibility” to disclose. This was particularly prevalent where there 
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was considerable interdependence within work teams or where they may need colleagues to 
cover work. 
I just again felt that I couldn’t be absent and coming and going in the way I would be 
and also expecting him to pick up work for me in my absence without being honest 
about why I wasn’t going to be there. (Sarah, partnered) 
 
Indeed, where participants did not disclose, their concerns about secrecy and not being 
‘honest’ created anxiety and conflict in combining work and treatment, leading to the 
realization that disclosure might be the better option.  
So when I had to go to like appointments or getting blood tests or whatever, you know, 
I just had to lie and sort of sneak around. Which I actually found more stressful than 
doing IVF. So it was really tricky (Ruth, single) 
 
Those who did not initially disclose felt that it became necessary to do so with more rounds 
of treatment or if treatment became challenging. 
I felt that I needed to tell him because I knew that potentially I was going to need time 
off again and it was going to be disruptive and it may end up in having a miscarriage 
again. (Charlotte, partnered) 
 
Workplace Relationships: shared values, experiences and friendships  
In all cases, workplace relationships were key to whether participants felt comfortable about 
disclosing ART treatment. For example, disclosure to a line manager or colleagues was more 
likely if participants felt they would understand because they had shared values in relation to 
work-life balance or childcare. In some cases managers or colleagues themselves had also 
disclosed personal experiences of ART treatment which created a context where the decision 
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to disclose was much easier  
I knew that he’s been through IVF three times himself, so it’s something I felt very 
comfortable talking to him about. (Yasmin, partnered) 
 
If line managers, in particular, were perceived as workaholics, lacking ‘work-life balance’ or 
did not have a family, participants were more reluctant to disclose. 
My boss is nearly 50, he’s single, and he’s divorced about three times. He has no 
intention of having children and he’s a workaholic. So, how can he ever, ever, really 
possibly understand what I’m going through? (Jackie, partnered) 
 
The most positive experiences were described as embedded in workplace friendships. That is 
relationships with line managers or colleagues often extended beyond just being work 
colleagues. This was associated with talk of telling friends at work about having ART 
treatment, legitimising the blurring of the boundaries between work and non-work spheres of 
life.  
It wasn’t even so relevant that they [colleagues] needed to know as such. My other 
colleagues are more friends, so I was feeling like I was telling something to a friend 
(Una, partnered)  
 
Workplace relationships associated with shared values, experiences or friendships created the 
most supportive experiences in the workplace, which involved both practical support for time 
off work for treatment and some emotional support. 
Obviously it made me feel better because he [line manager] did understand the 
pressures that you have to go through and the stress that it does bring on a person, 
but also the time off and things like that that I’d require. So, actually you couldn’t ask 
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for more understanding… (Polly, partnered) 
 
In summary, accounts of why participants disclosed ART use at work focused on two, 
partially overlapping themes: perceived lack of choice and relationships at work. Perceived 
lack of choice was largely attributed to lack of job flexibility which necessitated line manager 
support but also the need to be honest and transparent, especially because of interdependence 
of work teams. Workplace relationships were thus implicit in this theme but were more 
explicit in the second theme. The second theme pointed to the importance of shared values 
and experiences associated with empathy and even friendship, which made it easier to 
disclose. In contrast, lack of shared values and management capacity to understand the ART 
process created barriers to disclosure. 
  
Discussion 
This is the first in depth qualitative study to explore the experiences of individuals having 
ART treatment and to focus on disclosure of this treatment in the workplace. The confusion 
and ambivalence experienced by the participants in this study reflect the challenging nature 
of ART treatment, and this is rarely described in the literature (van den Akker, 2012). We 
found two main strands which reflected participants’ decisions to disclose: Concerns about 
disclosure and Motives for disclosure. Similar themes have emerged in research on cancer 
(Robinson et al., 2015) and mental health disclosure in the workplace (Brohan et al., 2012). 
However, concerns about and motives for disclosure in this study were related to participants’ 
unique experiences of ART treatment and concerns about blurring boundaries between the 
personal world of ART treatment and the public domain of work.  
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All participants expressed concerns about disclosing ART treatment, although the majority 
ultimately disclosed. However, privacy and intrusion concerns in the present study were not 
just about maintaining boundaries between the personal world of ART and work, but also 
about not wanting to be subjected to enquiries for updates about the success or failure of 
treatment. In particular, assisted conception was compared with natural family building 
where sex is seen as a private matter and people rarely disclose until at least 12 weeks into a 
pregnancy. Involuntary childlessness and the need to use ART were also felt to be 
stigmatizing. Stigma of involuntary childlessness (Throsby and Gill, 2004) and fears of 
judgement of using ART (Lee and Chu, 2001) are world-wide recognised problems, and are 
difficult to eradicate (van den Akker, 2012).  
 
Privacy and stigma were particularly pressing reasons not to disclose for men, who are 
known to feel stigmatised by involuntary childlessness, and single women, who are 
undergoing ART alone, as these are perceived as non-normative contexts for masculinity and 
family building respectively (Fisher and Hammarberg, 2012; van den Akker, 2016). In these 
cases, they will be disclosing more than just a possible future pregnancy at work, but their 
virility for men or relationship status for single women (King and Botsford, 2009). However, 
their choice not to disclose was sometimes limited. Some women thought they had no choice 
but to explain what they were doing to defend a change in behaviour or emotions at work. 
This choice was further limited where multiple unsuccessful treatments or miscarriages were 
experienced. Others felt they had to disclose to maintain their identity as a truthful person; to 
maintain their work image as a reliable employee; and because the burden of non-disclosure 
became too much. The benefits of the social support they may receive via disclosure at work 
(Mahajan et al, 2009) were therefore weighed up against the negative consequences of 
disclosure, as was found in other research on disclosure in the workplace (Robinson et al, 
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2015; Costello, 2009; Swan, 2005). However, where blurring of boundaries occurred due to 
colleagues being friends (or where there was shared values and experiences), especially 
positive consequences of disclosure were reported.  
 
Revealing and concealing involuntary childlessness can have identity implications (Bute, 
2013) and ‘disclosure disconnects’ may be experienced (Ragins, 2008). For example, in the 
workplace ART users discussed the problems associated with their identity as an employee 
versus as a prospective parent. Disclosure, for them meant potentially being discriminated 
against at work, as reported by King and Botsford (2009) in relation to pregnancy. Non-
disclosure, on the other hand, left them feeling a fraud to their colleagues (as reported by 
Creed and Scully, 2000). This suggests competing identities are fighting for recognition, and 
that more often than not, one needs to be sacrificed to save the other. Either way their 
commitment to their job could be questioned; if they disclosed they would be seen to be 
focused on family building and if they did not disclose they would appear to be an unreliable 
employee. Thus women ended up in a catch 22 situation whereby whether or not they 
disclosed and whether or not treatment was successful they could be seen as less committed.  
 
In the present study, a key reason for disclosure was ‘necessity’, but disclosure was also more 
likely where values and experiences were shared with the recipient, such as where the 
recipient had a family; had also experienced ART treatment; or was a friend. According to 
CPM theory (Petronio, 2002), disclosure is more likely to recipients (or communication 
partners) in these circumstances because the benefits of disclosure, such as obtaining 
workplace or social support, are more likely. Thus the boundaries between public and private 
information are rendered permeable and depend upon the individual situation. Similarly, 
theories of how people manage work and personal life, such as Border theory (Clarke, 2000) 
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and Boundary theory (Ashforth, Kreiner & Fugate, 2000) suggest that boundaries exist 
between work and personal life to keep the domains separate. However, borders or 
boundaries may also be blurred to help integrate domains where desired. In general, 
participants in the present study wished to keep the public domain of work and the personal 
world of ART separate, but where workplace friendships existed there tended to be a blurring 
of the boundaries. In contrast, the likelihood of non-disclosure increased if there was a lack of 
shared values or experiences, such as where line managers appeared to lack ‘work-life 
balance’ or did not have a family. Thus, as suggested by CPM theory, participants acted upon 
a number of competing needs and values which were dynamic and seemed to be adapted as 
the need to reveal more or less arose. However, reasons for disclosure based on recipients’ 
individual differences, rather than workplace policy or practices, can put employees in 
unfavourable positions with regards to disclosure. 
 
With the exception of concerns about privacy and stigma, the themes in the present study 
were less relevant to men, who, despite supporting their partners as much as possible, did not 
have to undergo the physical and emotional turmoil of the treatment to the same extent as the 
women. Bell (2016) refers to ART as “feminized”, as it excludes men from the same intense 
treatment experience, even where the diagnosis is male factor infertility. ART treatment by 
its very nature and in medical terms is therefore a gender specific issue, with a shared 
outcome but with the route to the outcome largely burdening the female partner. In the 
workplace, this is compounded by gendered assumptions about ideal workers, who do not 
allow personal life (Holt and Lewis, 2011) or problematic and unpredictable (female) bodies 
to interfere with work (Gatrell, 2011). Consequently, maintaining an existing identity as 
employee and co-worker was especially challenging for women participants in this study, and 
a new identity as prospective parent was difficult to disclose and difficult to adapt to. 
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Apprehensions about career consequences were reported by many of the women in this study, 
including fears that their career commitment would be questioned or that their career 
opportunities and progression would be undermined. These anticipated negative effects 
reflect, and add, to those experienced by other women requesting maternity leave and flexible 
working to accommodate childcare (King and Botsford, 2009; Hebl et al., 2007; Friedman, 
2001). Requesting additional time, over and above what naturally conceiving couples request 
might simply be considered too much by an employer; a concern raised by some of our 
participants. Interestingly, for other participants, having a child became such a priority that 
they were not concerned about their current or future careers, and wanted to focus on 
fulfilling this elusive aspiration. However, especially for single women, financial security is 
crucial to achieve this aspiration, because they are reliant on a single salary, and so concerns 
about career for more functional reasons may be a particular issue. 
 
These findings should be considered within some limitations to the present study, including it 
being based on a small and self-selected sample, which may have captured those with the best 
or worst experiences. There was also a lack of diversity in the sample as all participants were 
white and heterosexual, there were few men and single people, and there was no one who had 
given up on having a child. Given the sensitivity of the topic and difficulties recruiting 
volunteer participants it was beyond the scope of this study to recruit a more diverse sample. 
It is important for future research to take active steps to target more hard to reach groups, 
such as same sex couples, and also to extend the findings to a larger sample using survey 
methodology. Nevertheless, the findings have some potential practical implications. With the 
future need for assisted conception not likely to see a decline (HFEA, 2015), it is important 
that policies and practices address difficulties concerning disclosure that men and particularly 
women undergoing ART treatment experience in order to help them obtain support.  
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This study has shown that reasons for disclosure are work related and personal. Similarly, 
feeling they had no choice, concerns about their identity and the effects of disclosure upon 
their careers posed additional burdens on employees already compromised by difficulties 
conceiving. Clarity about entitlements to support and formal protection against 
discrimination, along with management training and awareness raising about ART treatment 
may help to normalise requests for support and make decisions about disclosure easier. 
However, the complexity of ART users experiences and conflicts concerning disclosure 
suggest that fundamental changes in negative assumptions about both involuntary 
childlessness and family building and ideal workers are needed. 
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